Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Annie Roy
Observed name:
ANNIE ROY
Observed institutions:
Héma-Québec,
Jewish General Hospital,
Université Laval
ORCID:
0000-0001-7504-6749
Observed ORCID:
0000-0001-7504-6749
OpenAlex ID:
A5103179515
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
2017
·
Sonia S Anand
, Jackie Bosch
, et al.
·
The Lancet
·
896
PDF
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
2017
·
Stuart J Connolly
, John W Eikelboom
, et al.
·
The Lancet
·
766
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
2021
·
Philippe Bégin
, Jeannie Callum
, et al.
·
Nature Medicine
·
261
PDF
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
2025
·
Javed Butler
, Ciaran J McMullan
, et al.
·
The Lancet
·
106
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event
2020
·
Carolyn S. P. Lam
, Anna Giczewska
, et al.
·
JAMA Cardiology
·
88
PDF
Intravenous immunoglobulins induce the in vitro differentiation of human B lymphocytes and the secretion of IgG
2003
·
Marie Joëlle de Grandmont
, Claudia Racine
, et al.
·
Blood
·
80
Characterization of mononuclear cells remaining in the leukoreduction system chambers of apheresis instruments after routine platelet collection: a new source of viable human blood cells
2007
·
Sonia Néron
, Louis Thibault
, et al.
·
Transfusion
·
73
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials
2025
·
Faiez Zannad
, Christopher M O'Connor
, et al.
·
The Lancet
·
63
Increased Efficiency of γ -Irradiated versus Mitomycin C-Treated Feeder Cells for the Expansion of Normal Human Cells in Long-Term Cultures
2001
·
Annie Roy
, Elizabeth Krzykwa
, et al.
·
Stem Cells and Development
·
62
Differential responses of human B‐lymphocyte subpopulations to graded levels of CD40–CD154 interaction
2005
·
Sonia Néron
, Claudia Racine
, et al.
·
Immunology
·
49
B cell proliferation following CD40 stimulation results in the expression and activation of Src protein tyrosine kinase
2006
·
Sonia Néron
, Garnet Suck
, et al.
·
International Immunology
·
34
Peripheral blood CD27+ IgG+ B cells rapidly proliferate and differentiate into immunoglobulin‐secreting cells after exposure to low CD154 interaction
2008
·
Jessie F. Fecteau
, Annie Roy
, et al.
·
Immunology
·
31
Large-Scale In Vitro Expansion of Polyclonal Human Switched-Memory B Lymphocytes
2012
·
Sonia Néron
, Annie Roy
, et al.
·
PLoS ONE
·
17
PDF
Telomere-independent Reduction of Human B Lymphocyte: Proliferation During Long-term Culture
2001
·
Daniel Jung
, Sonia Néron
, et al.
·
Immunological Investigations
·
13
Flow Cytometry Assessment of In Vitro Generated CD138+Human Plasma Cells
2014
·
Rayelle Itoua Maïga
, Jennifer Lemieux
, et al.
·
BioMed Research International
·
10
PDF
Modulation of CD40-activated B lymphocytes by N-acetylcysteine involves decreased phosphorylation of STAT3
2011
·
Philippe J. Nadeau
, Annie Roy
, et al.
·
Molecular Immunology
·
10
Effective in vitro expansion of CD40-activated human B lymphocytes in a defined bovine protein-free medium
2011
·
Sonia Néron
, Annie Roy
, et al.
·
Journal of Immunological Methods
·
8
Overview of IgG-Reactivity in Therapeutic immunoglobulins Revealed by Protein Array Analysis
2012
·
Sonia Néron
, Annie Roy
·
Biochemistry & Analytical Biochemistry
·
7
Estimation of the number of CD154 molecules in membrane extracts used as a source of CD40 stimulation of human B lymphocytes
2009
·
Éric Ducas
, Nathalie Dussault
, et al.
·
Journal of Immunological Methods
·
6
Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
2022
·
Philippe Bégin
, Jeannie Callum
, et al.
·
Nature Medicine
·
4
PDF
Persistent Polyclonal B Cell Lymphocytosis B Cells Can Be Activated through CD40-CD154 Interaction
2014
·
Emmanuelle Dugas-Bourdages
, Sonia Néron
, et al.
·
Advances in Hematology
·
4
PDF
Anti-Thyroglobulin IgG in Therapeutic Immunoglobulins: A Reactivity Bias in IgG4 Subclass
2014
·
Sonia Néron
, Annie Roy
, et al.
·
Open Journal of Immunology
·
3
PDF
The effect of vericiguat on sudden cardiac death: insights from the VICTOR trial
2026
·
Francesco Fioretti
, Faiez Zannad
, et al.
·
European Journal of Heart Failure
·
1
Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19
2022
·
Philippe Bégin
, Jeannie Callum
, et al.
·
Nature Medicine
·
1
CD19+,CD27+, IgM+ B Cells of Patients with Persistent Polyclonal B Cell (PPBL) Proliferate in a Low Intensity CD40-CD154 Interaction and Show Evidence of Immunoglobulin Isotype Switching
2008
·
Robert Delage
, Emmanuelle Dugas-Bourdages
, et al.
·
Blood
Show more works
View as search
Works count:
26
Citation count:
2,656
H-index:
14
I10-index:
17
Year
Topic
Type